Buy Agencium

A unique and innovative method for early cancer detection based on decades of research

Our Mission

At Vocoma, we believe that early cancer detection is a fundamental right and a necessity for all.

Our mission is to provide a universal, reliable, and accessible method for early cancer detection, empowering individuals to take control of their health and reduce the burdens that come with cancer.

Our innovative approach and method using VOC biomarkers sets new standards in the medical field for prevention and early cancer detection.

Innovation
Our research platform is committed to develop and push the boundaries of early cancer detection technology.
Accessibility
We believe in health equity and accessibility to everyone, regardless of their location or circumstance.
Reliability
Our platform is built on rigorous scientific research and clinical validation. Our results are highly reproducible and reliable.
Integrity
We operate with the highest standards of ethics, honesty and transparency.
Collaboration
We believe in the power of partnership with healthcare professionals, researchers, and organizations to enhance our technology and achieve our common goal.
Empowerment
We aim to empower individuals to take charge of their health, encouraging a proactive approach to cancer prevention and early detection.

Vocoma is committed
to make accurate and
early cancer detection
accessible to all.

Vocoma is committed to make accurate and early cancer detection accessible to all.

Benefits of early cancer detection

Increased survival rates among cancer patients
At early stages, cancer is localized and has not spread, resulting in significantly higher survival rates.
Better quality of life
quicker recovery of patients and less disruption of daily activities and overall well-being.
Reduction of pain and suffering of patients and their families
When treatments are effective with minimal damage, stress and anxiety levels are highly reduced. Furthermore, families with cancer history will be reassured to have an accurate method for early cancer detection and a remission with minimum damage.
More treatment options
A wide range of treatment options are often less aggressive and more effective, with fewer side effects than the treatments for advanced cancers.
Increased treatment success rate
Complete remission is possible if cancer is treated early which also reduces the risk of recurrence and secondary complications.
Lower treatment costs
Early treatment reduces the economic burden on both patients and the healthcare system.
Vocoma AG
Oberneuhofstrasse 10,
6340 Baar, Switzerland
Phone

+41 78 211 49 89

Social
Facebook-f Instagram Linkedin-in
Email

info@vocoma.com

© Vocoma AG 2025. All rights reserved.